Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/25576
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKarliychuk, Yulia-
dc.contributor.authorDudka, Inna-
dc.contributor.authorSmandych, Vitaliy-
dc.contributor.authorKrasnova, Taisiia-
dc.contributor.authorVarkhomiy, Petro-
dc.date.accessioned2024-09-27T09:27:33Z-
dc.date.available2024-09-27T09:27:33Z-
dc.date.issued2020-
dc.identifier.otherDOI: https://doi.org/10.12955/pmp.v1.97-
dc.identifier.otherUDC 612.2-
dc.identifier.urihttp://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/25576-
dc.description.abstractObjective: To establish the features of hemocoagulation and proteolytic hemostasis at COPD with concomitant CP. Conclusions: In COPD patients with accompanying CP are an increase in the lysis rate of low and high molecular weight proteins and a decrease in blood collagenolytic activity on the background of a significant imbalance in the activity of plasma proteinase inhibitors. Defined suppression of the activity of the anti-coagulation system factors and enzymatic, Hageman- factor-dependent fibrinolysis indicates the formation of hypercoagulation syndrome in these patients.uk_UA
dc.language.isoenuk_UA
dc.publisherCBU International Conference on Innovations in Science and Education 2020 (Medicine and Pharmacy) (March 18-20, Prague, Czech Republic)uk_UA
dc.subjectchronic obstructive pulmonary diseaseuk_UA
dc.subjectchronic pancreatitisuk_UA
dc.subjectfibrinolysisuk_UA
dc.subjectazoalbuminuk_UA
dc.titleInvestigation of external respiratory function and hemostasis system’s status in patients with chronic obstructive lung disease with concomitant chronic pancreatitisuk_UA
dc.typeArticleuk_UA
Appears in Collections:Статті

Files in This Item:
File Description SizeFormat 
Karliychuk et al. Investigation.pdf156.56 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.